Found: 5
Select item for more details and to access through your institution.
Population‐based study of disease trajectory after radical treatment for high‐risk prostate cancer.
- Published in:
- BJU International, 2024, v. 134, n. 1, p. 96, doi. 10.1111/bju.16362
- By:
- Publication type:
- Article
Safety and efficacy of apalutamide in Japanese patients with metastatic castration‐sensitive prostate cancer receiving androgen deprivation therapy: Final report for the Japanese subpopulation analysis of the randomized, placebo‐controlled, phase III TITAN study
- Published in:
- International Journal of Urology, 2022, v. 29, n. 6, p. 533, doi. 10.1111/iju.14843
- By:
- Publication type:
- Article
Real-World Safety and Efficacy Outcomes with Abiraterone Acetate Plus Prednisone or Prednisolone as the First- or Second-Line Treatment for Metastatic Castration-Resistant Prostate Cancer: Data from the Prostate Cancer Registry.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Real-World Outcomes in First-Line Treatment of Metastatic Castration-Resistant Prostate Cancer: The Prostate Cancer Registry.
- Published in:
- 2020
- By:
- Publication type:
- journal article
A Three-Arm Randomized Phase II Study of Oral Vinorelbine Plus Capecitabine Versus Oral Vinorelbine and Capecitabine in Sequence Versus Docetaxel Plus Capecitabine in Patients with Metastatic Breast Cancer Previously Treated with Anthracyclines.
- Published in:
- Breast Journal, 2013, v. 19, n. 3, p. 240, doi. 10.1111/tbj.12098
- By:
- Publication type:
- Article